Haw Par Valuation
| HAWPY Stock | USD 28.64 0.00 0.00% |
At this time, the firm appears to be fairly valued. Haw Par retains a regular Real Value of $28.64 per share. The prevalent price of the firm is $28.64. Our model calculates the value of Haw Par from evaluating the firm fundamentals such as Return On Equity of 0.0424, current valuation of (701.58 M), and Return On Asset of 0.0063 as well as inspecting its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Haw Par's price fluctuation is very steady at this time. Calculation of the real value of Haw Par is based on 3 months time horizon. Increasing Haw Par's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Haw Par is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Haw Pink Sheet. However, Haw Par's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 28.64 | Real 28.64 | Hype 28.64 |
The intrinsic value of Haw Par's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Haw Par's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Haw Par helps investors to forecast how Haw pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Haw Par more accurately as focusing exclusively on Haw Par's fundamentals will not take into account other important factors: Haw Par Total Value Analysis
Haw Par is currently projected to have takeover price of (701.58 M) with market capitalization of 1.8 B, debt of 762 K, and cash on hands of 596.23 M. The negative valuation of Haw Par may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should thoroughly investigate all of the Haw Par fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(701.58 M) | 1.8 B | 762 K | 596.23 M |
Haw Par Investor Information
The company has price-to-book (P/B) ratio of 0.73. Some equities with similar Price to Book (P/B) outperform the market in the long run. Haw Par last dividend was issued on the 19th of August 2022. Based on the analysis of Haw Par's profitability, liquidity, and operating efficiency, Haw Par is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Haw Par Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Haw suggests not a very effective usage of assets in December.Haw Par Profitability Analysis
The company reported the revenue of 141.18 M. Net Income was 116.18 M with profit before overhead, payroll, taxes, and interest of 73.64 M.About Haw Par Valuation
Our relative valuation model uses a comparative analysis of Haw Par. We calculate exposure to Haw Par's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Haw Par's related companies.Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company was incorporated in 1969 and is based in Singapore. Haw Par operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Haw Par's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Haw Par's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Haw Par's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Haw Par's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Haw Par's revenue streams: Identify Haw Par's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Haw Par's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Haw Par's growth potential: Evaluate Haw Par's management, business model, and growth potential.
- Determine Haw Par's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Haw Par's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Haw Par Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 55.3 M | |
| Quarterly Earnings Growth Y O Y | 0.46 | |
| Retained Earnings | 1.2 B |
Additional Tools for Haw Pink Sheet Analysis
When running Haw Par's price analysis, check to measure Haw Par's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haw Par is operating at the current time. Most of Haw Par's value examination focuses on studying past and present price action to predict the probability of Haw Par's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haw Par's price. Additionally, you may evaluate how the addition of Haw Par to your portfolios can decrease your overall portfolio volatility.